FAM189A1 inhibitors constitute a specialized class of chemical compounds designed to selectively modulate the activity of the Family with sequence similarity 189 member A1 (FAM189A1) protein. FAM189A1 is a relatively less-explored member of the FAM189 gene family, and its precise molecular functions and cellular roles are currently under investigation. The inhibitors developed for FAM189A1 possess a unique chemical structure that allows them to interact selectively with defined binding sites on the FAM189A1 protein, thereby influencing its molecular activities within the cellular context. The careful design of these inhibitors is crucial for ensuring a high degree of specificity, minimizing unintended effects on other cellular components or proteins within the broader FAM189 gene family.
The mechanism of action of FAM189A1 inhibitors involves disrupting the normal functioning of the FAM189A1 protein, potentially impacting cellular processes associated with its specific role. As researchers explore the complexities of gene families and their diverse functions, FAM189A1 inhibitors serve as valuable tools, allowing for the investigation of the precise molecular mechanisms governed by FAM189A1. The study of this chemical class contributes to a deeper understanding of the role played by FAM189A1 in cellular physiology, offering insights into its potential functions within the intricate networks that regulate gene expression and cellular processes. Overall, the exploration of FAM189A1 inhibitors provides a platform for advancing our understanding of the molecular landscape surrounding this lesser-known member of the FAM189 gene family and its implications in cellular functions yet to be fully elucidated.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Sirolimus, also known as rapamycin, inhibits the mTOR pathway, which can lead to changes in protein synthesis including potentially reducing FAM189A1 expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, and by affecting the PI3K/Akt pathway, it may alter transcription factor activity and gene expression, including FAM189A1. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, which is part of the MAPK/ERK pathway; this could lead to alterations in gene expression profiles, including FAM189A1. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor, which could modulate transcription factor activity, potentially affecting the expression of genes like FAM189A1. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAP kinase, which may influence gene expression and could reduce the expression of proteins such as FAM189A1. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent PI3K inhibitor and could change the phosphorylation status of various substrates, potentially affecting FAM189A1 expression. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
Gefitinib inhibits EGFR tyrosine kinase, which may lead to altered signaling pathways and potentially decrease the expression of FAM189A1. | ||||||
Erlotinib, Free Base | 183321-74-6 | sc-396113 sc-396113A sc-396113B sc-396113C sc-396113D | 500 mg 1 g 5 g 10 g 100 g | $87.00 $135.00 $293.00 $505.00 $3827.00 | 42 | |
Erlotinib is another EGFR inhibitor, and by blocking this pathway, it could affect transcriptional regulation of various genes, including FAM189A1. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Sorafenib targets multiple kinases and could disrupt signaling pathways, thereby potentially downregulating FAM189A1 expression. | ||||||
Sunitinib, Free Base | 557795-19-4 | sc-396319 sc-396319A | 500 mg 5 g | $153.00 $938.00 | 5 | |
Sunitinib is a receptor tyrosine kinase inhibitor and could affect multiple signaling pathways, possibly impacting FAM189A1 expression. | ||||||